Some studies indicate a very real and significant benefit from microdosing, whereas others are much less convincing and show little to no benefit. At least one state (Oregon), and many cities around the country, have decriminalized psychedelics at the local level. We don’t know as much about safety as we might have learned if not for the War on Drugs, which curtailed much of the research into psychedelics starting in the late 1960s. The drug could be adulterated (mixed in) with substances of a lower quality or dangerous product. It also means people consuming these substances cannot access a controlled, safe supply.
In 2017, Okour et al published the first example in literature of a termination of an oral drug based on IV microdose data. “If the story about ‘Clearlight Brand “microdose” LSD’ is true, then the origin of the term ‘microdose’ for very small doses of LSD precedes all other uses of the term, e.g. in pharmacology (since 1995), in agriculture (since 2005) and by Fadiman (2011).” For safety reasons, these patients are typically excluded from studies involving psychedelic drugs. It is important to mention that the use of all psychedelic drugs should be undertaken with utmost caution — if they should be used at all — in patients with major mental illness such as schizophrenia or bipolar disorder.
The Words of the Week – Nov. 28
Greater openness, curiosity, shifting perspectives, and overall greater feelings of creativity are commonly reported benefits. Such studies may not give a full depiction of the practice, since most of these participants already expect to have a good experience so their feedback may be biased. These tend to be the most researched and are often easier to obtain than some lesser-used substances.
Because of the promising potential seen in research on standard doses of psychedelic substances, the potential of microdosing as a mental health and substance use treatment warrants further research. Microdosing, or micro-dosing, involves the administration of sub-therapeutic doses of drugs to study their effects in humans, aiming to gather preliminary data on safety, pharmacokinetics, and potential therapeutic benefits without producing significant physiological effects. So while standard doses of psychedelics appear to offer some benefits, they are not always desirable due to the alterations in perceptions, cognitions, and emotions as well as the potential for unwanted side effects. Some research suggests that psychedelics (at full doses) may help relieve some mental health conditions including anxiety and depression.
Is it safe to microdose a GLP-1 drug?
This is called a “Phase 0 study” and is usually conducted before clinical Phase I to predict whether a drug is viable for the next phase of testing. Finally, it is important to understand that there isn’t yet definitive proof that microdosing is at all helpful, or even that it is safe in the long term. In one example the researchers conducted a randomized controlled study, which represents the strongest type of evidence because it weeds out the placebo effect.
We and our partners process data to provide:
Skeptics are worried that uncontrolled access to these drugs might affect patients with mental illness, or might even precipitate mental illness such as psychosis in people that are vulnerable. It is anticipated by experts in the field that some psychedelics may become fully legalized — for medical usage, under supervision — within the next few years, specifically psilocybin and MDMA (ecstasy). Further, psychedelics such as psilocybin and LSD can produce physiological tolerance, which might suggest that, even if microdosing does help, there could be diminishing returns if one stays at the same dosage.
How Much Is a Microdose?
That said, there may be factors like side effects that prompt doctors to consider deviating from the FDA’s dosing guidance. And then I even had a handful of patients that were taking less frequently than that, and people maintaining their weight doing that.” “Several patients in my study were taking them every 10 days instead of every week,” he says.
Free Healthbeat Signup
Microdosing means taking a tiny fraction of a full dose of psychedelic substances, such as lysergic acid diethylamide (LSD or “acid”) or psilocybin mushrooms (magic mushrooms). Microdosing is not for everyone, and people with mental health disorders or symptoms should not use the practice to replace any treatment. However, there is not much formal research into this practice yet, partly because most substances that people microdose are illegal and difficult to research. Drug tests that check for these substances may be able to pick up on microdoses. A 2019 study notes that roughly a fifth of those that microdose report some kind of psychological or physical negative effects. A 2023 review suggests that microdoses of psilocybin could help to enhance creativity in adults.
However, they are Schedule I substances under the Controlled Substances Act, making them illegal to treatment for alcohol consume in any quantity. Psilocybin and LSD, for example, are commonly cited in microdosing research. There is a risk of taking too much and experiencing an unwanted psychedelic “trip.”
Microdosing Risks
Some people think microdosing psychedelics can boost mood, creativity, and more. No arrows from existing clinical evidence point to starting a GLP-1 drug with the intention of microdosing it. The results of Dr. Biermann’s study aren’t published yet, but his initial data shows that spacing out how often patients took their medication could be an effective maintenance strategy for people who never reach the maximum dose.
- For safety reasons, these patients are typically excluded from studies involving psychedelic drugs.
- Generally, it involves taking about 5% to 10% of a recreational dose of a hallucinogenic substance.
- As only microdose levels of the drug are used, analytical methods are limited.
The illegality of microdosing substances limits research opportunity and quality. These small doses do not cause any notable changes in consciousness or sensations. Many people who try it may find that the effects are not to their liking. More research is still necessary to not only determine whether microdosing is helpful, but if they are safe in the long-term.
But, this doesn’t mean that there is any research that shows that microdosing a GLP-1 drug is recommended, Dr. Kansal says. “The original clinical trials for GLP-1s show these drugs are not only for weight loss but also weight maintenance, as obesity is a chronic disease. We asked doctors who prescribe GLP-1 medications to break down this trend and explain whether it’s worth it to consider microdosing a GLP-1 drug. Unlike the FDA-approved dosing regimen for GLP-1s, there is no published evidence to support “microdosing” these medications to achieve weight loss.
- For some people, this means purchasing the drug from an international manufacturer or compounding pharmacy to access non-standard doses, explains Mitch Biermann, MD, PhD, an internal and obesity medicine specialist at Scripps Clinic.
- And you don’t know if middlemen have added other substances.
- One study found that MDMA tablets are often mixed with other substances including bath salts and only 60% of these tablets even contained any MDMA at all.
- No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
- It has energizing effects and enhances feelings of empathy and self-awareness.
Researchers are investigating into microdosing more and more, the placebo effect causes difficulties in research on this topic. More research is needed to ultimately decide whether or not microdosing helps those who suffer from depression and anxiety.
